Connolly SJ, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361:1139-1151
Dabigatran (Pradaxa) is non-inferior to warfarin for the prevention of strokes or systemic embolism, in non-valvular atrial fibrillation.
Tag: NEJM
Jun 22 2011
Dabigatran versus warfarin for atrial fibrillation
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1443
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1065
Feb 02 2011
Effect of home testing of INR on clinical events
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=282
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=206
Recent Comments